Future of Drug Discovery Informatics Market

Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking, Library Preparation), Solution (Software, Services), End User (Pharmaceutical & Biotechnology, Contract Research Organization)

(EMAILWIRE.COM, May 17, 2019 ) In the current market scenario, there is a growing demand for discovery informatics solutions. The major factors driving the growth of the global market include the rising R&D expenditure, the increasing focus on drug discovery, and need to control the drug discovery and development cost.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64537381

On the other hand, the scarcity of skilled professionals, and high pricing and setup cost of informatics software are the major factors restraining the growth of this market.

The global drug discovery informatics market is projected to reach USD 2.84 Billion in 2022 from USD 1.50 Billion in 2016, at CAGR of 11.2% during forecast period.

The base year considered for the study is 2016, and the forecast for the market size is provided for the period between 2017 and 2022

The key players in the drug discovery informatics market are IBM (US), Infosys (India), Schrödinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US). These players focus on inorganic strategies such as acquisitions, agreements, and collaborations as well as organic strategies such as product launches and expansions to sustain their growth in the global market.

Request for Sample @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=64537381

Target Audience:
-Providers drug discovery informatics solution
-Pharmaceutical companies
-Academic institutes
-Biotechnology companies
-Research institutes
-Government associations
-Contract research organizations (CROs)